Pharmacy Practice News

Pharmacy Practice News (PPN) aims to deliver precise, pertinent, and current information to health-system pharmacists to enhance their clinical practices. The website not only offers the latest news but also features various regular elements from the magazine, such as Continuing Education courses, updates on new FDA drug approvals, and our well-respected educational reviews.

National, Trade/B2B

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#1514291

United States

#406887

Health/Pharmacy

#699

Traffic sources

Monthly visitors

Articles

Telepharmacy Brings Home SUD Therapy

1 day ago | pharmacypracticenews.com | Heidi Splete

By Heidi SpleteHome-based delivery of care for substance use disorder (SUD) is safe, effective and feasible for pharmacists to put into practice, according to experts at the ASHP Midyear 2024 Clinical Meeting & Exhibition, in New Orleans.
Most Patients Can Safely Remain on GLP-1s Before Surgery

2 weeks ago | pharmacypracticenews.com | Ashley Welch

Originally published by our sister publication Specialty Pharmacy ContinuumMost patients can continue taking glucagon-like peptide-1 (GLP-1) receptor agonists before undergoing elective surgery, according to new multi-specialty guidance from gastroenterologists, surgeons and anesthesiologists.
Pharmacists Play Important Role in Melanoma Education

3 weeks ago | pharmacypracticenews.com | Karen Blum

Counseling survivors of melanoma on sun protection and skin health is an important role for pharmacists, said Lisa Holle, PharmD, BCOP, FHOPA, FISOPP, a clinical professor of pharmacy practice at the University of Connecticut School of Pharmacy, in Storrs. “This cannot be emphasized enough,” Dr. Holle said.
ACIP Recommends Bavarian Nordic’s Chikungunya Vaccine

3 weeks ago | pharmacypracticenews.com | Marie Rosenthal

Originally published by our sister publication Infectious Disease Special EditionBy Marie Rosenthal, MSThe CDC’s Advisory Committee on Immunization Practices voted to recommend the virus-like particle-based chikungunya vaccine, recombinant (CHIK-VLP; Vimkunya, Bavarian Nordic) for certain populations. However, the CDC has not acted yet on this or other recommendations the ACIP made April 16.
Trump Prescription Drug Order Puts Spotlight on Price Tensions for Biosimilars

3 weeks ago | pharmacypracticenews.com | Fran Kritz

Originally published by our sister publication Specialty Pharmacy Continuum By Fran Kritz On April 15, President Trump issued an executive order aimed at lowering prescription drug prices that requires the FDA commissioner to issue a report within 180 days “providing administrative and legislative recommendations to accelerate approval of generics, biosimilars, combination products, and second-in-class brand name medications.” In a fact sheet the White House summarized efforts to increase the...
Ensitrelvir Reduces COVID-19 Risk by 67%

3 weeks ago | pharmacypracticenews.com | Marie Rosenthal

Ensitrelvir, an antiviral being developed to prevent COVID-19, reduced the risk of developing the infection by 67% in uninfected people after exposure to SARS-CoV-2 compared with placebo at day 10, according to results presented at CROI 2025, held in San Francisco (abstract 200). The 67% reduction is “super exciting,” said Diane Havlir, MD, the CROI chair, and the chief of the HIV, Infectious Diseases and Global Medicine Division at Zuckerberg San Francisco General Hospital and Trauma Center.
Anticoagulation End-of-Life Management Considerations

3 weeks ago | pharmacypracticenews.com | Karen Blum

Patient preferences, anticoagulant benefit versus risk and limited life expectancy should be considered when managing anticoagulation treatment at the end of a patient’s life. “We have a lot of guidelines that cover when to start anticoagulants, but they’re conspicuously lacking for when and how to stop them,” said Anna Parks, MD, an assistant professor and the director of thrombosis at the University of Utah, in Salt Lake City.
ACIP Recommends GSK’s 5-in-1 Meningococcal Vaccine

4 weeks ago | pharmacypracticenews.com | Marie Rosenthal

Originally published by our sister publication Infectious Disease Special EditionBy Marie Rosenthal, MSThe CDC’s Advisory Committee on Immunization Practices (ACIP) recommended the use of meningococcal groups A, B, C, W and Y vaccine (MenABCWY; Penmenvy, GSK) as part of the adolescent meningococcal vaccination schedule to protect against disease-causing serogroups of Neisseria meningitidis (A, B, C, W and Y). On Feb.
ACIP Recommends Expanded Use for RSV Vaccines

1 month ago | pharmacypracticenews.com | Marie Rosenthal

Originally published by our sister publication Infectious Disease Special EditionBy Marie Rosenthal, MSIn a unanimous vote, the CDC’s Advisory Committee on Immunization Practices (ACIP) voted to expand its recommendation for the use of respiratory syncytial virus vaccines to adults 50 to 59 years of age at increased risk for RSV-associated lower respiratory tract disease (LRTD). This includes people with conditions such as chronic obstructive pulmonary disease (COPD), asthma,
Better Clinical Outcomes Seen With Fetroja as Empiric, Not Salvage Therapy

1 month ago | pharmacypracticenews.com | Marie Rosenthal

Originally published by our sister publication Infectious Disease Special EditionBy Marie Rosenthal, MSA higher clinical cure rate was found among patients with serious gram-negative bacterial infections who received cefiderocol (Fetroja, Shionogi) as empiric therapy or for a documented infection than among those given it as salvage therapy, according to a presentation at ESCMID Global 2025, in Vienna (poster P2542).